News
Activist Starboard Value, one of the first investors to publicly push Salesforce to make changes three years ago, increased ...
17hon MSN
Got the sniffles? Here’s what to know about summer colds and the COVID-19 variant called stratus
COVID-19 activity is rising in much of the country. Data shows overall respiratory virus spread is very low in the U.S.
The Nobel Prize-winning technology underpinning COVID-19 vaccines is also fueling a host of biotechs developing treatments ...
9hon MSN
FDA considering pulling authorization of Pfizer’s COVID-19 vaccine for healthy children under 5
The Food and Drug Administration is considering pulling its authorization of Pfizer’s COVID-19 vaccine for healthy children ...
The U.S. Food and Drug Administration may not renew its authorization for Pfizer's COVID-19 vaccine approved for children ...
The move would add another barrier for parents who want to vaccinate healthy children ahead of the respiratory virus season.
They’re turning their backs on a technology thought to have saved millions of lives—with the potential to save many more.
“We’ve stepped back into the world that we lived in before the [CDC’s vaccine advisory committee] was created,” said Dr.
In this Q&A, Rohit Nambisan, CEO of Lokavant, and Jonathan Crowther, head of predictive analytics, Pfizer, explore how AI is ...
In Westport, an Irish town transformed by a pharmaceutical plant that manufactures the world’s Botox, there are fears ...
President Donald Trump ordered administration officials to draw up a list of 26 key drugs to develop a stockpile in the ...
Can Boston stay on top in biotech? Find out on Sept 17, 6-9 p.m. EDT to explore talent shifts, funding, and Boston’s future.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results